Patents

US 12703726 B2: Compositions and methods for the treatment of cystic fibrosis

Granted
2026-08-11
Filed
2021-04-27 application 17921510
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are polynucleotides, lentiviral vectors, pharmaceutical compositions, and methods of making and using the same, e.g., for treatment of cystic fibrosis (CF).

Source: PTBLXML, file of 2026-08-11 (ipgb20260811.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
University of Iowa Research Foundation 401 patentsUS company or organizationIowa City, IAUNIVERSITY OF IOWA RESEARCH FOUNDATION Nonprofit EXACT high confidence: identical full name and statePTBLXML, file of 2026-08-11

Inventors

InventorPlacePatentsPerson pageSource
Paul B. McCray, Jr.Iowa City, IAPTBLXML, file of 2026-08-11
Patrick SinnIowa City, IA3PTBLXML, file of 2026-08-11
Laura Marquez LozaIowa City, IAPTBLXML, file of 2026-08-11

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/4712PTBLXML, file of 2026-08-11
A61KPreparations for medical, dental or toiletry purposesA61K9/0078PTBLXML, file of 2026-08-11
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/86PTBLXML, file of 2026-08-11

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.